| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |